AI assistant
Hester Biosciences Ltd — Capital/Financing Update 2018
Dec 25, 2018
62222_rns_2018-12-25_f4c36293-270b-438b-8fff-5bc26f22ea45.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [521 x 95] intentionally omitted <==
25 December 2018
To, To, BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Dalal Street, Bandra - Kurla Complex, Mumbai - 400 001 Bandra (E), Mumbai - 400 051 Scrip Code: 524669 Symbol: HESTERBIO
Respected Sir/Madam:
Subject: Intimation of assigned Credit Ratings
Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("the Regulations"), we would like to inform that Credit Analysis and Research Limited ('CARE Ratings'), vide it's letter dated 24 December 2018, has assigned the followings ratings to the Company:
| Credit Facility | Existing Ratings | Revised Ratings | Remark |
|---|---|---|---|
| Long - term BankFacilities | CARE "A- : Stable"(Single A Minus:Outlook: Stable) | CARE "A- : Stable"(Single A Minus:Outlook: Stable) | Reaffirmed |
| Long - term /Short - term BankFacilities | CARE "A- : Stable" /CARE "A2"(Single A Minus:Outlook: Stable/ A Two) | CARE "A- : Stable" /CARE "A2"(Single A Minus:Outlook: Stable/ A Two) | Reaffirmed |
| Short - term BankFacilities | - | CARE "A2"(A Two) | Assigned |
Kindly take note of the same and consider in your records.
Sincerely, For, Hester Biosciences Limited Rajiv Gandhi CEO & Managing Director DIN: 00438037